NCT05587374 Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05577702 Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT05576272 A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05570422 A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 Status RECRUITING Phase PHASE1
NCT05555732 Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05541016 De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA Status RECRUITING Phase PHASE2
NCT05535166 Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma Status RECRUITING Phase PHASE2
NCT05527470 Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Status RECRUITING Phase PHASE3
NCT05524168 SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05522894 AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC Status UNKNOWN Phase PHASE2
NCT05521997 Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT05516589 Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC Status COMPLETED Phase PHASE2
NCT05514912 Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial Status WITHDRAWN Phase PHASE2
NCT05502237 Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05498220 Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma Status TERMINATED Phase PHASE2
NCT05494190 The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma Status RECRUITING Phase NA
NCT05493501 Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT05491512 A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer Status RECRUITING Phase PHASE2
NCT05489848 Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT05489211 Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Status RECRUITING Phase PHASE2